RI
RTW Investments Portfolio holdings
AUM
$7.02B
This Quarter Return
+4.29%
1 Year Return
+28.16%
3 Year Return
+245.48%
5 Year Return
+425.65%
10 Year Return
+5,642.23%
AUM
$6.63B
AUM Growth
+$6.63B
(+0.06%)
Cap. Flow
+$484M
Cap. Flow
% of AUM
7.3%
Top 10 Holdings %
Top 10 Hldgs %
41.1%
Holding
130
New
17
Increased
26
Reduced
9
Closed
10
Top Buys
| 1 |
Thermo Fisher Scientific
TMO
|
$238M |
| 2 |
Penumbra
PEN
|
$103M |
| 3 |
Tenaya Therapeutics
TNYA
|
$48.6M |
| 4 |
argenx
ARGX
|
$32.8M |
| 5 |
MacroGenics
MGNX
|
$29.9M |
Top Sells
| 1 |
QuidelOrtho
QDEL
|
$113M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
$52.8M |
| 3 |
Protagonist Therapeutics
PTGX
|
$31.1M |
| 4 |
TRIL
Trillium Therapeutics Inc.
TRIL
|
$20.3M |
| 5 |
MiMedx Group
MDXG
|
$14.6M |
Sector Composition
| 1 | Healthcare | 91.48% |
| 2 | Financials | 0.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Rocket Pharmaceuticals
RCKT
$354M
| $470M | 7.08% | 15,802,802 +812,516 | +5% | +$24.1M |
|
|
2
SPDR S&P 500 ETF Trust
SPY
$658B
| $375M | 5.65% | 873,255 -123,000 | -12% | -$52.8M |
|
3
Alnylam Pharmaceuticals
ALNY
$58.5B
| $318M | 4.79% | 1,683,362 | – | – |
|
|
MRTX
4
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $264M | 3.98% | 1,492,532 +35,000 | +2% | +$6.19M |
|
|
5
Thermo Fisher Scientific
TMO
$186B
| $238M | 3.58% | +416,000 | New | +$238M |
|
6
Masimo
MASI
$7.59B
| $225M | 3.4% | 832,540 +6,330 | +0.8% | +$1.71M |
|
7
Vericel Corp
VCEL
$1.83B
| $220M | 3.32% | 4,517,570 | – | – |
|
8
Celldex Therapeutics
CLDX
$1.47B
| $211M | 3.18% | 3,908,947 | – | – |
|
9
Natera
NTRA
$23.1B
| $208M | 3.13% | 1,862,234 +150,000 | +9% | +$16.7M |
|
10
PTC Therapeutics
PTCT
$3.92B
| $197M | 2.97% | 5,293,966 | – | – |
|
11
Illumina
ILMN
$15.8B
| $196M | 2.95% | 482,791 | – | – |
|
12
Establishment Labs
ESTA
$1.2B
| $166M | 2.5% | 2,319,138 | – | – |
|
|
DRNA
13
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $153M | 2.31% | 7,582,396 +60,537 | +0.8% | +$1.22M |
|
14
Tandem Diabetes Care
TNDM
$845M
| $139M | 2.09% | 1,160,734 +13,326 | +1% | +$1.59M |
|
15
Globus Medical
GMED
$8.27B
| $128M | 1.93% | 1,670,811 | – | – |
|
|
AXNX
16
DELISTED
Axonics, Inc. Common Stock
AXNX
| $127M | 1.91% | 1,943,864 | – | – |
|
17
Avidity Biosciences
RNA
$5.99B
| $118M | 1.78% | 4,795,000 +800,000 | +20% | +$19.7M |
|
18
Guardant Health
GH
$8.41B
| $116M | 1.74% | 925,342 +7,089 | +0.8% | +$886K |
|
19
C4 Therapeutics
CCCC
$185M
| $111M | 1.68% | 2,494,965 +345,737 | +16% | +$15.4M |
|
|
ISEE
20
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $109M | 1.65% | 6,722,624 | – | – |
|
21
Fulcrum Therapeutics
FULC
$351M
| $109M | 1.64% | 3,855,291 +650,000 | +20% | +$18.3M |
|
22
10x Genomics
TXG
$1.74B
| $107M | 1.61% | 734,481 | – | – |
|
|
23
Penumbra
PEN
$10.6B
| $103M | 1.55% | +385,194 | New | +$103M |
|
|
DMTK
24
DELISTED
DermTech, Inc. Common Stock
DMTK
| $100M | 1.51% | 3,118,665 | – | – |
|
25
Stoke Therapeutics
STOK
$1.08B
| $92.7M | 1.4% | 3,644,248 | – | – |
|